Manzo Pharmaceuticals Inc

(MNZO) Follow

By |

Profile

Manzo Pharmaceuticals Inc manufactures and sells products and owns patents in the field of supplemental and holistic cures sold through retail and online distribution.

Contact Information

Website:	www.manzopharma.com/
Main Phone:	+1 570 249-6000
Address:	PO Box 107
Address 2:	Suite 305
State:	PA
City / Town:	Milford
Country:	USA
Postal Code:	18337

Issuer Information

Exchange:	CVEM
NAICS:	Pharmaceutical Preparation Manufacturing(325412)

$ 0.0001 $ 0. (0.00%)

Last Price 0.0001	Change $ 0.	Change % 0.00	Tick N/A
Bid N/A	Bid Size N/A	Ask N/A	Ask Size N/A
Open 0.0001	High 0.0001	Low 0.0001	Prev Close 0.0001
Last Trade Sep/21 - 10:49	Volume 90,000	52 Wk Hi 0.0055	52 Wk Low 0.0001
Market Cap 535	Ex-Div Date N/A	Div Rate N/A	Yield N/A
Shares 5,345,439.00	EPS (TTM) 1.70	PE Ratio 0.00	Exchange CV EM

News

Mina Mar Group (MMG) Client Update (KNSC) (CSCE) (TMXN) (SIPC) (FOGC)
August 01, 2014 - 11:02
Nutra Pharma Corp. and Nyloxin To Begin Airing Television Commercials
June 12, 2014 - 17:23
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act - Form D
March 25, 2011 - 00:00
Certification of termination of registration of a class of security under Section 12(g) or notice of suspension of duty to file reports under Section 13 and 15(d) of the Act Section 12 (g) - Form 15-12G
July 30, 2010 - 00:00
Amendment to a previously filed Form 5 - Form 5/A
March 02, 2007 - 00:00
Annual statement of changes in beneficial ownership of securities - Form 5
February 13, 2007 - 00:00
Notification that form 10-Q will be submitted late - Form NT 10-Q
April 28, 2006 - 00:00
Report of unscheduled material events or corporate changes - Form 8-K
April 12, 2006 - 00:00
Notification that form 10-K will be submitted late - Form NT 10-K
March 28, 2006 - 00:00
Amendment to a previously filed 10SB12G - Form 10SB12G/A
March 10, 2006 - 00:00